Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Renal hyperfiltration related to diabetes mellitus and obesity in human disease

Open access
Sasson, Alexa N·2012·World Journal of Diabetes

Abstract

High intraglomerular pressure is associated with renal hyperfiltration, leading to the initiation and progression of kidney disease in experimental models of diabetes mellitus (DM). In humans, hyperfiltration is observed in patients with type 1 and type 2 DM, and is also seen in patients with pre-diabetic conditions, such as the metabolic syndrome. From a mechanistic perspective, both vascular and tubular factors likely contribute to the pathogenesis of hyperfiltration. Until now, human studies have primarily focused on the use of medications that inhibit the renin angiotensin system to reduce efferent vasoconstriction and thereby improve hyperfiltration. More recent advances in the development of investigational adenosine antagonists and inhibitors of sodium glucose co-transport may help to elucidate tubular factors that contribute to afferent vasodilatation. In this review, we summarize available data from experimental and human studies of type 1 and type 2 DM and obesity to provide an overview of factors that contribute to the hyperfiltration state. We have focused on the renin angiotensin system, cyclooxygenase-2 system, nitric oxide, protein kinase C and endothelin as vascular determinants of hyperfiltration. We also discuss relevant tubular factors, since experimental models have suggested that inhibition of sodium-glucose cotransport may be renoprotective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4239/wjd.v3.i1.1

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 73

  1. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993;265:F477-F486. · DOI · Paper page
  2. 10.1016/0026-0495(87)90070-9 · DOI · Paper page
  3. 10.1038/ki.1981.33 · DOI · Paper page
  4. 10.1073/pnas.82.17.5963 · DOI · Paper page
  5. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999;10:2569-2576. · DOI · Paper page
  6. Park SK, Kang SK. Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med 1995;10:48-53. · DOI
  7. 10.1007/s00125-009-1268-0 · DOI · Paper page
  8. 10.1093/ndt/16.7.1382 · DOI
  9. 10.1007/s00125-010-1794-9 · DOI · Paper page
  10. 10.1038/sj.ki.5002160 · DOI · Paper page
  11. 10.2174/157339908786241151 · DOI
  12. 10.1172/JCI112521 · DOI · Paper page
  13. 10.2337/diabetes.49.7.1258 · DOI
  14. 10.1038/ki.1993.183 · DOI · Paper page
  15. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000;11:71-79. · DOI · Paper page
  16. O'Byrne S, Forte P, Roberts LJ, Morrow JD, Johnston A, Anggård E, Leslie RD, Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000;49:857-862. · DOI
  17. 10.3317/jraas.2004.006 · doi:10.3317/jraas.2004.006
  18. 10.2337/db07-1230 · DOI
  19. 10.2337/dc09-2340 · DOI
  20. 10.1152/ajprenal.00574.2007 · DOI
  21. Ichihara A, Imig JD, Navar LG. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure. Hypertension 1999;34:843-847. · DOI
  22. 10.1172/JCI10228 · DOI · Paper page
  23. 10.1038/ki.1996.265 · DOI · Paper page
  24. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006;17:1703-1709. · DOI
  25. 10.2337/dc08-1609 · DOI
  26. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000;14:439-447. · DOI · Paper page
  27. 10.1126/science.272.5262.728 · DOI · Paper page
  28. Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 2006;55:3112-3120. · DOI · Paper page
  29. 10.1016/S0895-7061(98)00094-6 · doi:10.1016/s0895-7061(98)00094-6
  30. 10.3109/00365519609088813 · doi:10.3109/00365519609088813
  31. 10.1007/s001250051308 · DOI
  32. 10.1016/S0026-0495(98)90314-6 · doi:10.1016/s0026-0495(98)90314-6
  33. 10.2337/diacare.21.6.1004 · DOI
  34. Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int 1994;46:376-381. · doi:10.1038/ki.1994.284
  35. Sørensen SS, Madsen JK, Pedersen EB. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994;266:F411-F418. · doi:10.1152/ajprenal.1994.266.3.f411
  36. 10.1161/01.CIR.0000118499.69469.51 · DOI · Paper page
  37. 10.1111/j.1365-2125.2005.02503.x · doi:10.1111/j.1365-2125.2005.02503.x
  38. 10.1681/ASN.2009060593 · DOI · Paper page
  39. 10.1681/ASN.2008050482 · DOI · Paper page
  40. Aires I, Calado J. BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus. Curr Opin Investig Drugs 2010;11:1182-1190.
  41. 10.1681/ASN.2007060721 · DOI
  42. 10.1111/j.1365-2362.2005.01497.x · DOI
  43. 10.1097/01.ASN.0000051700.07403.27 · DOI · Paper page
  44. Vallon V, Wead LM, Blantz RC. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J Am Soc Nephrol 1995;5:1761-1767. · DOI
  45. 10.1038/sj.bjp.0703829 · DOI · Paper page
  46. Malatiali S, Francis I, Barac-Nieto M. Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats. Exp Diabetes Res 2008;2008:305403. · DOI
  47. Strojek K, Yoon KH, Hruba V, Elze M, Langkilde AM, Parikh S. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial. Diabetes Obes Metab 2011;13:928-938. · DOI · Paper page
  48. 10.1056/NEJMoa0912613 · DOI · Paper page
  49. Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, Smits P. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension 1999;34:1080-1085. · DOI
  50. 10.2337/dc10-0767 · DOI
  51. 10.1152/ajpregu.00853.2005 · DOI
  52. 10.1152/ajpregu.00693.2005 · DOI
  53. 10.1016/S1056-8727(02)00196-4 · DOI
  54. 10.1016/S0168-8227(01)00260-1 · DOI
  55. 10.2337/diabetes.54.7.2206 · DOI
  56. 10.1007/s00125-005-0002-9 · DOI
  57. 10.1152/ajprenal.00421.2010 · DOI
  58. 10.2215/CJN.02350607 · DOI
  59. 10.1159/000110566 · DOI
  60. 10.1038/ncpneph0565 · DOI
  61. 10.1093/ndt/gfq008 · DOI
  62. 10.1053/j.ajkd.2010.03.017 · DOI
  63. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996;28:127-132. · DOI · Paper page
  64. 10.1161/01.HYP.0000132568.71409.a2 · DOI
  65. 10.1080/10739680701283018 · DOI
  66. 10.1097/01.ASN.0000068462.38661.89 · DOI · Paper page
  67. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822. · DOI · Paper page
  68. 10.1007/s12020-009-9224-9 · DOI
  69. 10.1159/000185377 · doi:10.1159/000185377
  70. 10.1093/ndt/gfn379 · DOI · Paper page
  71. 10.2215/CJN.03691106 · DOI
  72. 10.2337/dc09-1303 · DOI
  73. 10.1111/j.1464-5491.2010.03121.x · DOI

Cited by

See all 158

Metadata

Authors
Sasson, A. N.
Venue
World Journal of Diabetes
Published
2012
Volume
3
Issue
1
Pages
1
ISSN
1948-9358 (ISSN-L)
OpenAlex
W2075475582
Cited by
158
References
7
FWCI
8.80
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal hyperfiltration related to diabetes mellitus and obesity in human disease. https://app.cochat.ai/papers/10.4239/wjd.v3.i1.1
The paper
Sasson, A. N. (2012). Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World Journal of Diabetes. https://doi.org/10.4239/wjd.v3.i1.1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.